Jeremiah Anthony Wala

  • Boston, MA
  • Medical oncologist
NPI1932669249PAC ID4587073291
Part D claims, 2024
27
Hospital affiliations
2
Medical group
1
State license
1
Year NPI issued
2019
Practice address
450 Brookline Avenue, Boston, MA 02115
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Dana-Farber Cancer Institute

Hospital · Boston, Massachusetts

Find Jeremiah Wala's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Jeremiah Anthony Wala is a medical oncologist in Boston, Massachusetts

Jeremiah Wala practices at Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute.

Jeremiah Wala's NPI, 1932669249, was assigned on March 22, 2019. Jeremiah Wala graduated from Harvard Medical School in 2019. Jeremiah Wala holds Massachusetts license 1016218.

NPI and contact details
Medicare PAC ID
4587073291
NPI enumeration date
March 22, 2019
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
33
Medical school graduation
2019

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Jeremiah Anthony Wala practices at Dana-Farber Cancer Institute in Boston, Massachusetts

Jeremiah Wala's primary practice is Dana-Farber Cancer Institute, at 450 Brookline Avenue, Boston, MA 02115.

Source: Dmand AI Affiliation Data

Jeremiah Anthony Wala is affiliated with 2 sites of care and 1 medical group

Jeremiah Wala's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Jeremiah Wala is also affiliated with Brigham and Women's Hospital. The medical group on file is Binney Medical Group.

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Jeremiah Anthony Wala's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Jeremiah Wala practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dana-Farber Cancer InstituteAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Jeremiah Wala practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Dana-Farber Cancer Institute and 6.2K+ hospitals, with verified contacts in the same login.

Jeremiah Anthony Wala is one of 290 medical oncologists in Massachusetts

Medical oncology is Jeremiah Wala's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Jeremiah Wala is licensed in Massachusetts.

Specialties and state licenses

  • Medical oncology, MassachusettsPrimaryLicense 1016218 · taxonomy 207RX0202X

Medical oncologists near Jeremiah Wala

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Jeremiah Anthony Wala's patients have a median age of 71

Across all payers, Dmand AI patient panel data puts Jeremiah Wala's median patient age at 71, with 10% women.

Jeremiah Wala's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 71

Patient panel by sex, all payers

  • Women10%
  • Men88%

Source: Dmand AI Patient Panel Data

Jeremiah Anthony Wala wrote 27 Medicare Part D claims in 2024

In 2024, Jeremiah Wala wrote 27 Medicare Part D claims for 22 patients. 81% of them were for generic drugs.

Part D claims, 202427
Part D patients22

Jeremiah Wala's Part D claims by kind of drug, 2024

  • Generic22 claims81%
  • Brand-name and other5 claims19%

Source: Medicare Part D Prescribers - by Provider (CMS), 2024 data

Jeremiah Anthony Wala offers telehealth to Medicare patients

Jeremiah Wala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jeremiah Wala as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find medical oncologists like Jeremiah Wala by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Jeremiah Anthony Wala graduated from Harvard Medical School

Jeremiah Wala graduated from Harvard Medical School in 2019.

  1. Medical schoolHarvard Medical School

Source: Dmand AI Professional Profile Data

Sources for Jeremiah Anthony Wala's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Jeremiah Anthony Wala

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Jeremiah Anthony Wala's NPI number?

Jeremiah Anthony Wala's NPI number is 1932669249. It was assigned on March 22, 2019, and it is active in the NPI Registry.

What does Jeremiah Anthony Wala specialize in?

Jeremiah Anthony Wala is a medical oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Jeremiah Anthony Wala practice?

Jeremiah Wala practices at 450 Brookline Avenue, Boston, MA 02115. Jeremiah Wala's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute.

What is Jeremiah Anthony Wala's medical license number?

Jeremiah Wala holds Massachusetts license 1016218.

Which hospitals is Jeremiah Anthony Wala affiliated with?

Jeremiah Wala practices at Dana-Farber Cancer Institute in Boston, Massachusetts. Jeremiah Wala is also affiliated with Brigham and Women's Hospital.

What medical group is Jeremiah Anthony Wala part of?

Jeremiah Wala is linked to Binney Medical Group.

Does Jeremiah Anthony Wala accept Medicare?

Yes. CMS lists Jeremiah Wala as accepting Medicare assignment.

Does Jeremiah Anthony Wala offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Jeremiah Wala as offering telehealth services.

Where did Jeremiah Anthony Wala go to medical school?

Jeremiah Wala graduated from Harvard Medical School in 2019.

How long has Jeremiah Anthony Wala been practicing?

Jeremiah Wala graduated from medical school in 2019, 7 years ago.

Selling to medical oncology practices?

See medical oncologists in Massachusetts by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)